Picture of Immix Biopharma logo

IMMX — Immix Biopharma News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Brief: Immix Biopharma Accelerates Enrollment In U.S. AL Amyloidosis Trial Of NXC-201 CAR-T

Jan 7 (Reuters) - Immix Biopharma Inc  IMMX.O :
    * IMMIX BIOPHARMA ACCELERATES ENROLLMENT IN U.S. AL
AMYLOIDOSIS
TRIAL OF NXC-201 CAR-T
    * IMMIX BIOPHARMA INC: ON TRACK FOR NEXT PROGRAM UPDATE IN
Q1 2025

Source text:  ID:nGNX1WJxc4 
Further company coverage:  IMMX.O 

 (((( Reuters.Briefs@thomsonreuters.com ;));))

Recent news on Immix Biopharma

See all news